4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-22-000155
SVP Corporate Strategy-Develop sold 5 shares at $81.63 ($408)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dolan Matthew Vincent SVP Corporate Strategy-Develop | 2022-09-01 | Sale | −5 | $81.63 | $408 | 26,536 | D |
| Open-market sales · 5 sh · avg $81.63 · $408 | |||||||
Loading xslF345X03/edgardoc.xml…